AI-Powered Intelligence

The intelligent platform for clinical drug development

Accelerate drug development decisions with AI-powered document analysis, indication evaluation, technology scouting, and regulatory intelligence — all in one platform.

Book a Demo ▶ Watch Platform Demo
60%
Time Saved on Research
5
Therapeutic Areas
10+
Data Sources Integrated

Trusted by clinical development teams at

BIOTECH CO
PHARMA INC
MEDTECH GLOBAL
CLINICAL LABS
GENOMICS PLUS
NEURO SCIENCES
BIOTECH CO
PHARMA INC
MEDTECH GLOBAL
CLINICAL LABS
GENOMICS PLUS
NEURO SCIENCES

How Otalytix Works

Three pillars of clinical intelligence

From raw data to actionable insights — Otalytix powers every stage of your clinical development research.

Analyze

AI-powered document analysis, literature review, and regulatory intelligence. Automatically extract insights from publications, FDA filings, clinical trial data, and conference proceedings.

Evaluate

Map clinical development pathways, scout emerging technologies, and benchmark competitive landscapes. Data-driven frameworks that clarify your path from candidate selection to regulatory submission.

Act

AI agent capabilities, knowledge graphs, and real-time monitoring. Get proactive alerts on competitive moves, regulatory updates, and clinical trial milestones across your pipeline.

Platform Features

Everything you need for clinical intelligence

AI-Powered Document Analysis

Upload publications, FDA filings, patent documents, or conference posters. Otalytix extracts key findings, generates structured summaries, and identifies connections across your entire document library.

  • Automatic extraction from PDFs, CSVs, and web sources
  • Cross-reference across PubMed, FDA, and clinical trial databases
  • Structured summaries with source citations
Feature Screenshot

Data-Driven Indication Scoring

Evaluate therapeutic indications with quantitative scoring across market size, competitive intensity, regulatory complexity, and scientific feasibility. Compare opportunities side by side.

  • Multi-criteria scoring framework
  • Market landscape and pipeline analysis
  • Exportable reports for investment committees
Feature Screenshot

Emerging Technology Scouting

Stay ahead of the curve with AI-driven technology scouting. Monitor emerging modalities, novel delivery systems, and breakthrough platform technologies relevant to your therapeutic areas.

  • Real-time monitoring of patents and publications
  • Company and startup landscape mapping
  • Deal flow tracking and partnership analysis
Feature Screenshot

Regulatory Intelligence Advisor

Navigate FDA, EMA, and global regulatory landscapes with AI-powered guidance. Track approval precedents, guidance updates, and advisory committee decisions relevant to your programs.

  • FDA drug label and approval history analysis
  • Regulatory pathway recommendations
  • Precedent mapping for similar compounds
Feature Screenshot

Clinical Trials Intelligence

Monitor clinical trial activity across your competitive landscape. Track enrollment, endpoints, results, and timelines with real-time data from ClinicalTrials.gov and global registries.

  • Real-time trial tracking and alerts
  • Endpoint and enrollment analysis
  • Competitive pipeline visualization
Feature Screenshot

Interactive Knowledge Graphs

Visualize relationships between drugs, targets, indications, companies, and clinical outcomes. Our dynamic knowledge graphs reveal connections that traditional research methods miss.

  • Dynamic force-directed graph visualization
  • Cross-domain relationship discovery
  • Exportable insights for presentations
Feature Screenshot

Therapeutic Areas

Specialized suites for every therapeutic area

Each suite is purpose-built with curated data sources, evaluation frameworks, and competitive intelligence tailored to the unique needs of each disease area.

Ophthalmology
Ophthalmology

Wet AMD, dry AMD, geographic atrophy, DME, diabetic retinopathy, RVO, uveitis, and myopic CNV
Oncology
Oncology

NSCLC, SCLC, TNBC, HER2+ breast, colorectal, melanoma, RCC, HCC, pancreatic, bladder, and ovarian cancers
Neurology
Neurology

Alzheimer's, Parkinson's, MS (RRMS, SPMS, PPMS), ALS, Huntington's, FTD, myasthenia gravis, and SMA
Immunology
Immunology

Rheumatoid arthritis, psoriasis, Crohn's, ulcerative colitis, atopic dermatitis, lupus, asthma, and GVHD
Cardiometabolic
Cardiometabolic

Obesity, T2DM, ASCVD, heart failure, MASH/NASH, CKD, hypertension, dyslipidemia, and atrial fibrillation
Rare Disease
Rare Disease

Orphan indications, gene therapies, enzyme replacement, and ultra-rare conditions with custom ontologies
Custom

Custom therapeutic area configuration tailored to your company's pipeline and disease focus

Proven Impact

Save 60% of your clinical research time

Teams using Otalytix save an average of 15 hours per analyst per week on manual research, literature review, and competitive intelligence gathering.

15 hrs
Saved per analyst / week
60%
Reduction in research time
10x
Typical ROI in year one
Calculate Your ROI

What Teams Say

Trusted by clinical development professionals

"Otalytix has transformed how our team approaches competitive intelligence. What used to take days of manual research now takes hours, with better coverage and more actionable insights."

VP of Clinical Strategy

Mid-stage Biotech Company

"The indication evaluation framework gave us a data-driven foundation for our portfolio prioritization. We identified two high-potential indications we would have missed with traditional methods."

Head of Business Development

Top-20 Pharmaceutical Company

"The real-time regulatory monitoring alone has paid for itself. We were alerted to a competitor's label change three days before our board meeting — that insight was invaluable."

Director of Regulatory Affairs

Specialty Pharma Company

Ready to transform your clinical development?

Join leading biotech and pharma teams using Otalytix to make faster, better-informed drug development decisions.

Book a Demo View Pricing